Human Interleukin-3 (nonglycosylated) Uses, Dosage, Side Effects and more
Human Interleukin-3 (nonglycosylated) is under investigation in clinical trial NCT00002258 (A Phase I, Open Label Trial to Evaluate the Safety, Tolerance and Biological Effects of SDZ ILE-964 (Recombinant Human Interleukin-3, RhIL-3) in HIV Infected Patients With Cytopenia).
| Attribute | Details |
|---|---|
| Trade Name | Human Interleukin-3 (nonglycosylated) |
| Generic | Muplestim |
| Muplestim Other Names | Human interleukin-3 (nonglycosylated), Interleukin 3, Interleukin 3 (human), Interleukin-3, Interleukin-3 human (recombinant), Multipotential colony-stimulating factor, Muplestim |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
